A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer

A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer

10.1038/ng.3374

Saved in:

Bibliographic Details
Main Authors:	Aminkeng, Folefac, Bhavsar, Amit P, Visscher, Henk, Rassekh, Shahrad R, Li, Yuling, Lee, Jong W, Brunham, Liam R, Caron, Huib N, van Dalen, Elvira C, Kremer, Leontien C, van der Pal, Helena J, Amstutz, Ursula, Rieder, Michael J, Bernstein, Daniel, Carleton, Bruce C, Hayden, Michael R, Ross, Colin JD
Other Authors:	DEAN'S OFFICE (MEDICINE)
Format:	Article
Language:	English
Published:	NATURE PUBLISHING GROUP 2022
Subjects:	Science & Technology Life Sciences & Biomedicine Genetics & Heredity TRANS-RETINOIC ACID GENETIC POLYMORPHISMS DOXORUBICIN THERAPY HEART-FAILURE HIGH-RISK SURVIVORS LEUKEMIA ASSOCIATION CHILDREN VISUALIZATION
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/235119
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

Similar Items

Pharmacogenomic screening for anthracycline-induced cardiotoxicity in childhood cancer
by: Aminkeng, Folefac, et al.
Published: (2022)

Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity
by: Aminkeng, Folefac, et al.
Published: (2022)

Predicting Anthracycline-induced Cardiotoxicity in Children - Genome-Wide Association Study
by: Aminkeng, Folefac, et al.
Published: (2022)

Multifactorial Prediction of Anthracycline-Induced Cardiotoxicity in Childhood Cancer: 10 Years of Active Surveillance and Pharmacogenomics Studies at the Canadian Pharmacogenomics Network for Drug Safety
by: Aminkeng, Folefac, et al.
Published: (2022)

An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclines
by: Dionne, Francois, et al.
Published: (2022)

Cardiotoxicity After Anthracycline Chemotherapy for Childhood Cancer in a Multiethnic Asian Population
by: Tan, VZZ, et al.
Published: (2021)

Modeling Doxorubicin-Induced Cardiotoxicity in Human Pluripotent Stem Cell Derived-Cardiomyocytes
by: Maillet, A, et al.
Published: (2020)

Cardiotoxicity of antimalarial drugs
by: Nicholas J. White
Published: (2018)

No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine
by: M. Van Vugt, et al.
Published: (2018)

Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes
by: Wright, Galen EB, et al.
Published: (2022)

Clinical Practice Recommendations for the Management and Prevention of Cisplatin-Induced Hearing Loss Using Pharmacogenetic Markers
by: Lee, JW, et al.
Published: (2022)

Use of cardiac markers for monitoring of doxorubixin-induced cardiotoxicity in children with cancer
by: Pongprot Y., et al.
Published: (2014)

Molecular basis of cardiotoxicity upon cobra envenomation
by: Cher, C.D.N., et al.
Published: (2012)

Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine
by: Cheah, Irwin K, et al.
Published: (2023)

Increasing anthracyclines efficacy in Triple Negative Breast Cancer cells by disrupting cells defense mechanism and evaluating Caspase-3 as indicator for anthracyclines hematologic toxicity in breast cancer patients
by: Luo, Man
Published: (2020)

Short report: No evidence of cardiotoxicity of atovaquone-proguanil alone or in combination with artesunate
by: Ravindra K. Gupta, et al.
Published: (2018)

The protective roles of nitric oxide and superoxide dismutase in adriamycin-induced cardiotoxicity
by: Marsha P. Cole, et al.
Published: (2018)

Incidence of febrile neutropenia among early-stage breast cancer patients receiving anthracycline-based chemotherapy
by: Chan, A., et al.
Published: (2014)

Cardiotoxicity of uremic toxins: A driver of cardiorenal syndrome
by: Suree Lekawanvijit
Published: (2018)

Chemotherapy-Induced Cardiotoxicity: Overview of the Roles of Oxidative Stress
by: Paweorn Angsutararux, et al.
Published: (2018)

Phase II study of gemcitabine and carboplatin in metastatic breast cancers with prior exposure to anthracyclines and taxanes
by: Chan, D., et al.
Published: (2014)

Inhibitory effects of anthracyclines on partially purified 5′–3′ DNA helicase of Plasmodium falciparum
by: Pongruj Rattaprasert, et al.
Published: (2022)

Inhibitory effects of anthracyclines on partially purified 5′–3′ DNA helicase of Plasmodium falciparum
by: Rattaprasert P.
Published: (2023)

P-glycoprotein and vacuolar ATPase synergistically confer anthracycline resistance to fission yeast and human cells
by: Tay, Z., et al.
Published: (2014)

Antioxidative and cytoprotective effects of Phyllanthus urinaria L. on doxorubicin-induced cardiotoxicity
by: Linda Chularojmontri
Published: (2007)

Use of cardiac markers for monitoring of doxorubixin-induced cardiotoxicity in children with cancer
by: Yupada Pongprot, et al.
Published: (2018)

Preliminary in vitro permeability, cytotoxicity and cardiotoxicity evaluation of triazole-quinuclidine T6
by: Kuntarat Arunrungvichian, et al.
Published: (2020)

The arrhythmogenic cardiotoxicity of the quinoline and structurally related antimalarial drugs: A systematic review
by: Ilsa L. Haeusler, et al.
Published: (2019)

Identification of cardiotoxic ornamental plant species commonly found in Thailand by DNA analysis
by: S. Chalermrungroj, et al.
Published: (2018)

CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines
by: Drogemoller, Britt I, et al.
Published: (2022)

The emerging era of pharmacogenomics: current successes, future potential, and challenges
by: Lee, JW, et al.
Published: (2022)

Comparison of exercise training and estrogen supplementation on mast cell-mediated doxorubicin-induced cardiotoxicity
by: Sukanya Phungphong, et al.
Published: (2020)

NA+/K+ ATPASE: A POTENTIAL THERAPEUTIC TARGET FOR THE TREATMENT OF DOXORUBICIN-INDUCED CARDIOTOXICITY
by: LENG BIN
Published: (2024)

Roles of pharmacogenomics in non-anthracycline antineoplastic-induced cardiovascular toxicities: A systematic review and meta-analysis of genotypes effect
by: Siew Lian Leong, et al.
Published: (2019)

Purification and characterization of a novel 3′-5′ DNA helicase from Plasmodium falciparum and its sensitivity to anthracycline antibiotics
by: P. Suntornthiticharoen, et al.
Published: (2018)

Roles of pharmacogenomics in non-anthracycline antineoplastic-induced cardiovascular toxicities: A systematic review and meta-analysis of genotypes effect
by: Siew Lian Leong, et al.
Published: (2020)

Extracellular Vesicle Proteome of Breast Cancer Patients with and Without Cognitive Impairment Following Anthracycline-based Chemotherapy: An Exploratory Study
by: Koh, YQ, et al.
Published: (2022)

Effects of doxorubicin-induced cardiotoxicity on cardiac mitochondrial dynamics and mitochondrial function: Insights for future interventions
by: Nichanan Osataphan, et al.
Published: (2020)

Mollification of doxorubicin (DOX)-mediated cardiotoxicity using conjugated chitosan nanoparticles with supplementation of propionic acid
by: Siva, Durairaj, et al.
Published: (2022)

Evaluating a novel cardioprotective agent against DOX-induced cardiotoxicity in transgenic zebrafish model
by: Wong, Sze Ching
Published: (2015)